Xyall raises €6.0M Series B round
24 May 2022· Eindhoven, The Netherlands· health, diagnostics, robotics, ai, b2b, software_hardware
The funding was raised to accelerate the commercialisation of its Tissector High Throughput and Tissector Table Top systems, helping pathologists obtain more reliable molecular diagnostic test results.
Investors
LeadHealth Investment Partners
Also participating
BOM Brabant VenturesSioux Technologies
About Xyall
Stage
Series C
Headquarters
Eindhoven, The Netherlands
Founded
2018
Team Size
21–50
Sectors
healthdiagnosticsroboticsaib2bsoftware_hardware
Source: https://siliconcanals.com/crowdfunding/xyall-secures-6m/